The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Open accessAbstract
Key Points: The inhibitor incidence in nonsevere hemophilia A patients with certain F8 mutations approaches the inhibitor incidence in severe patients. These findings are highly relevant for clinical practice, as they facilitate identification of high-risk patients based on F8 genotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom
Hay, C. R. M., Palmer, B., Chalmers, E., Liesner, R., Maclean, R., Rangarajan, S., Williams, M., Collins, P. W., & on behalf of United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) (2011) · Blood · doi:10.1182/blood-2010-09-308668 · Cited by 174
Self-citation
Cited by
The past and future of haemophilia: diagnosis, treatments, and its complications
Peyvandi, F., Garagiola, I., & Young, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01123-x · Cited by 505
Berntorp, E., Fischer, K., Hart, D. P., Mancuso, M. E., Stephensen, D., Shapiro, A. D., & Blanchette, V. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00278-x · Cited by 328
Self-citationLenting, P. J., Denis, C. V., & Christophe, O. D. (2017) · Blood · doi:10.1182/blood-2017-08-801662 · Cited by 269
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
Samelson-Jones, B. J., & Arruda, V. R. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.007 · Cited by 58
Hemophilia gene therapy comes of age
George, L. A. (2017) · Hematology · doi:10.1182/asheducation-2017.1.587 · Cited by 58
Metadata
- Authors
- Eckhardt, C. L., van Velzen, A. S., Peters, M., Astermark, J., Brons, P. P., Castaman, G., Cnossen, M. H., Dors, N., Escuriola-Ettingshausen, C., Hamulyak, K., Hart, D. P., Hay, C. R. M., Haya, S., van Heerde, W. L., Hermans, C., Holmström, M., Jimenez-Yuste, V., Keenan, R. D., Klamroth, R., Laros-van Gorkom, B. A. P., Leebeek, F. W. G., Liesner, R., Mäkipernaa, A., Male, C., Mauser-Bunschoten, E., Mazzucconi, M. G., McRae, S., Meijer, K., Mitchell, M., Morfini, M., Nijziel, M., Oldenburg, J., Peerlinck, K., Petrini, P., Platokouki, H., Reitter-Pfoertner, S. E., Santagostino, E., Schinco, P., Smiers, F. J., Siegmund, B., Tagliaferri, A., Yee, T. T., Kamphuisen, P. W., van der Bom, J. G., & Fijnvandraat, K.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-09-12
- Volume
- 122
- Issue
- 11
- Pages
- 1954-1962
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2169013901
- Cited by
- 220
- References
- 2
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. https://app.cochat.ai/papers/10.1182/blood-2013-02-483263
- The paper
- Eckhardt, C. L., van Velzen, A. S., Peters, M., Astermark, J., Brons, P. P., Castaman, G., Cnossen, M. H., Dors, N., Escuriola-Ettingshausen, C., Hamulyak, K., Hart, D. P., Hay, C. R. M., Haya, S., van Heerde, W. L., Hermans, C., Holmström, M., Jimenez-Yuste, V., Keenan, R. D., Klamroth, R., . . . Fijnvandraat, K. (2013). Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood. https://doi.org/10.1182/blood-2013-02-483263
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.